A research
study titled, “Pharmaceutical
Packaging Equipment Market by Product and Package Type – Global Industry Analysis and
Forecast to 2025” published by Crystal Market Research, states that the
pharmaceutical packaging equipment market is projected to be around $10.5
billion by 2025.
Pharmaceutical
packaging equipment is a machine which is used to pack pharmaceutical product
for the purpose of safety. Packaging will keep the pharmaceutical product free
from external toxins, microbial growth and help to extend their shelf life by
protecting them against all external influences that can alter the property of
products. Pharmaceutical packaging material includes primary packaging system,
secondary packaging system and tertiary packaging system.
The various
containers used for pharmaceutical products are bottle, blister, ampoule,
cartridge, single dose container, tube and vial. The raw materials which are
used for pharmaceutical packaging includes plastic, glass, paper, cardboard,
metal and rubber. The global market for pharmaceutical packaging equipment is
expected to witness high growth owing to increase in demand for new and
flexible packaging equipment, and technological advancements related to
labeling.
The liquid
packaging equipment segment occupied the largest share of the overall market in
2016, due to increasing demand for automation and increase in prevalence of eye
and ear disorders resulting in increased use of liquid dosage. Based on
packaging type,the primary packaging segment held the major share of the
overall market in 2016, due to technological advancements and increasing
regulatory modifications related to pharmaceutical product packaging. The
aseptic filling and sealing equipment segment dominated the global primary
packaging equipment market in 2016.
Regional
Outlook of Pharmaceutical Packaging Equipment Market
North America occupied the largest share of the overall market in 2016, due to R&D expenditure and existence of major pharmaceutical companies in this region.Asia-Pacific is poised to grow at highest rate during the forecast period. This is attributed to factors such as increasing aging population, rise in manufacturing activities and rapid development in pharma and biotech infrastructure. Moreover, theNorth American and European pharmaceutical companies are outsourcing their manufacturing processes to Asian countries due to low labor cost, which is further contributing to the market growth.
North America occupied the largest share of the overall market in 2016, due to R&D expenditure and existence of major pharmaceutical companies in this region.Asia-Pacific is poised to grow at highest rate during the forecast period. This is attributed to factors such as increasing aging population, rise in manufacturing activities and rapid development in pharma and biotech infrastructure. Moreover, theNorth American and European pharmaceutical companies are outsourcing their manufacturing processes to Asian countries due to low labor cost, which is further contributing to the market growth.
Key Market Players of Pharmaceutical
Packaging Equipment Market:
Uhlmann-Group, Romaco Pharmatechnik GmbH, MULTIVAC, Körber AG, I.M.A. IndustriaMacchine Automatiche S.p.A., OPTIMA packaging group GmbH, Robert Bosch Gmbh, MG2 s.r.l., Bausch &StröbelMaschinenfabrikilshofenGmbh Co. Kg. and Marchesini Group S.p.A.
Uhlmann-Group, Romaco Pharmatechnik GmbH, MULTIVAC, Körber AG, I.M.A. IndustriaMacchine Automatiche S.p.A., OPTIMA packaging group GmbH, Robert Bosch Gmbh, MG2 s.r.l., Bausch &StröbelMaschinenfabrikilshofenGmbh Co. Kg. and Marchesini Group S.p.A.
Key Findings of the Research Study:
The liquid packaging equipment segment held the major share of the overall market in 2016, due to increase in prevalence of eye and ear disorders.
The liquid packaging equipment segment held the major share of the overall market in 2016, due to increase in prevalence of eye and ear disorders.
The primary
packaging segment held the major share of the overall market in 2016, due owing
to increase in need for unit dosage forms.
North
America accounted for one-third share of the global market in 2016, due to
advancements in packaging technology and rise in demand for single unit liquid
doses.
Asia-Pacific
is poised to grow at highest rate during the forecast period as large number of
pharma and biotech companies from U.S. and Europe are outsourcing their
manufacturing operations due to low labor cost.
Comments
Post a Comment